E.W. Scripps aims to build new franchises in women’s sports at a moment when bigger rivals are hoping to do the same. After ...

E.W. Scripps is emphasizing women’s sports on broadcast network ION and more targeted programming on Court TV and Bounce in ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

Truist raised the firm’s price target on Elevance Health (ELV) to $510 from $480 and keeps a Buy rating on the shares as part of a broader ...

So it is hard to draw any strong conclusion from it. Insiders in Elevance Health didn't buy any shares in the last year. The chart below shows insider transactions (by companies and individuals ...

Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Elevance Health (NYSE:ELV) with a Buy recommendation.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $512.00. The ...

Importantly, Elevance Health, Inc. (NYSE:ELV) does carry debt. But the more important question is: how much risk is that debt creating? Debt assists a business until the business has trouble ...